Insider Shareholders with Direct Ownership of Iterum Therapeutics PLC (ITRM)
This section provides a comprehensive overview of the insiders with direct ownership of Iterum Therapeutics PLC (ITRM). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Iterum Therapeutics plc Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Canaan X L.P.
Director |
1,733,170 | 0 | 1,733,170 $3.26 Million | 1 |
May 30, 2018
Added 22.62%
|
| 463,258 | 33,143 | 220,001 $413,601 | 16 |
Aug 06, 2024
Added 32.57%
|
|
|
Corey N. Fishman
Chief Executive Officer |
489,446 | 91,128 | 137,062 $257,676 | 7 |
Aug 06, 2024
Added 37.61%
|
|
Beth Hecht
Director |
60,293 | 0 | 18,839 $35,417 | 3 |
Jun 15, 2023
Added 45.7%
|
|
Mark Chin
Director |
52,651 | 11,857 | 18,306 $34,415 | 3 |
Jun 15, 2023
Added 46.41%
|
| 48,311 | 0 | 14,346 $26,970 | 5 |
Oct 01, 2023
Added 27.64%
|
|
|
Sailaja Puttagunta
Chief Medical Officer |
16,667 | 6,298 | 10,369 $19,493 | 4 |
Dec 01, 2023
Reduced 22.05%
|
|
Judith M. Matthews
Chief Financial Officer |
169,166 | 140,013 | 8,135 $15,293 | 7 |
Mar 11, 2023
Reduced 26.17%
|